Introduction
All living cells are constantly exposed to a number of physical forces. Repair and development of an organ or a tissue is governed by the integration of both physical forces and chemical signals (Mammoto and Ingber (2010) . These physical forces comprise both endogenous forces such as cytoskeletal contractility and exogenous forces such as shear stress and interstitial fluid flow. Cells sense and respond to these different cues to maintain homeostasis. However, in pathological conditions such as fibrosis (Ban and Twigg, 2008) and cancer (Swartz and Lund, 2012 ) these adaptive mechanisms are disrupted.
The microenvironments of growing tumours and healing wounds are known to be highly dynamic (Schultz et As most studies on TGF-1-induced fibroblast differentiation have been pursued in a static culture environment, it is highly likely that TGF-1 stimulated fibroblasts may show variations in their phenotype in a physiologically relevant, dynamic environment in which cells experience both physical forces and chemical signals.
The aim of this study was to investigate the response of fibroblasts to mechanical forces and chemical signals in a physiologically relevant dynamic environment. We report that fluid flow confers an "activated phenotype to normal fibroblasts and this differentiation is reversed when flow is withdrawn, and reduced in the presence of exogenous TGF-1. We reveal that increased levels of TGF-1 and activin A may mediate this activation of fibroblasts by flow, and that an increase in endocytosis including internalisation of TGF-RII could explain the reduced response to TGF-1 under flow. Our results provide the first evidence of fluid flow mediated "tensional homeostasis" that buffers the fibroblast phenotype in response to pro-differentiation signals such as TGF-1 and mechanical forces experienced in vivo. Figure 1a . Using this approach, we identified 2944 transcripts differentially expressed between dermal fibroblasts in static and flow conditions (p<0.05) at both flow rates (75 and 150 µl/min) (Fig. 1b) . The Volcano plot of the top 100 genes displaying variations in their expression under fluid flow (150 µl/min) compared to static (Fig 1c) . Principal Component Analysis (PCA) of the 2944 genes altered in dermal fibroblasts subjected to flow treatment (75 and 150 µl/min) shows that the first principal component containing the majority of variability in these genes clearly separates the samples exposed to static conditions from the samples exposed to fluid flow (75 and 150 l/min) (Fig.1d) . In order to further characterise the effects of fluid flow on fibroblasts the transcripts altered under flow (75 and 150 µl/min) were examined for functional enrichment. The KEGG pathways which were most highly changed under flow were the TGFsignalling pathway and genes associated with clathrin and caveolin-mediated endocytosis. (Fig 2c, d ).
Results

Dermal
Dermal fibroblasts treated with fluid flow (150 µl/min) revealed intense staining of -SMA rich stress fibres whereas TGF-1 supplemented and flow treated fibroblasts show very little -SMA staining (Fig. 2e) . Notably, these immunofluorescence studies on -SMA expression are concordant with the results from gene expression analysis.
However, when dermal fibroblast subjected to fluid flow (150 µl/min) for 24h. were allowed to rest in static conditions for 24h., the intensity of -SMA staining decreased (Fig.2f) .
To study the functional role of TGF-pathway in fluid flow induced fibroblast activation by treating dermal fibroblasts with fluid flow for 2h. TGF-1 supplemented and flow treated fibroblasts were used as positive controls. Expression of phosphorylated SMAD3 was studied by immunofluorescence (Fig 2g) . and by western blotting (Fig 2h) . Immunofluorescence findings indicated that phosphorylated SMAD3 protein translocated to the nucleus under fluid flow treatment as well as in TGF-1 supplemented and flow treated fibroblasts.
Concordantly, protein blot analysis of phosphorylated SMAD3 also showed increase in protein expression when fibroblasts were subjected to fluid flow.
Cell associated and secreted TGF-1 is enhanced under fluid flow.
To assess effect of fluid flow on protein expression of TGF-1, we extracted protein samples from both cellular lysate and conditioned medium of dermal fibroblasts subjected to flow (150µl/min) and static treatments. Secreted TGF-1 in conditioned medium ( Fig. 3a) and cell associated TGF-1 ( 
Materials and Methods
Reagents and antibodies: All of the reagents used in this study were purchased from Sigma unless otherwise stated. The antibodies used are shown in Table 1 .
Cell Culture
Normal oral fibroblasts (NOF-320) were derived from ethically approved waste tissues produced during oral surgical procedures undertaken at the Charles Clifford Dental Hospital, Sheffield, UK. Normal human dermal fibroblasts (NHDFC) were purchased from Promocell. Fibroblasts from both sources were cultured in DMEM supplemented with 10% (v/v) foetal calf serum (FCS) and 1% penicillin/streptomycin.
Oral fibroblasts were used from a single donor at passage numbers between 3 and 5and experiments were repeated three times. This study was approved by the
University of Sheffield Ethics committee. (Ethics Committee approval Ref:
07/H1309/105).
Experimental design using the Quasi Vivo bioreactor
The Quasi-Vivo bioreactor (Kirkstall Limited, UK) is composed of chambers of polydimethyl-siloxane (PDMS), interconnected in a series (Fig. 1a) . 
Microarray analysis
The effect of fluid flow was studied by subjecting dermal fibroblasts to varying fluid flow rates in the bioreactor for 24h. RNA was obtained from dermal fibroblasts Immunofluorescence staining -SMA protein was detected in dermal fibroblasts subjected to a flow rate of 150µl/ min for 24 h. Cells were stimulated with 10ng/ml TGF-1 (R&D systems) in both static and flow conditions. Cells were fixed in 100% methanol and permeabilised with 4 mM sodium deoxycholate. Non-specific binding was blocked with 2.5% bovine serum albumin (BSA) in PBS followed by incubation with FITC conjugated anti-alpha smooth muscle actin ( -SMA) antibody in blocking buffer for one hour at 37ºC.
Fibroblasts treated with fluid flow at a rate of 150µl/ min for 24 h. were left in static conditions for a further 24h and stained for -SMA protein as above.
Dermal fibroblasts subjected to a flow rate of 150 µl/ min for 2 h. were labelled for phospho-SMAD3, CAV-1A, EEA-1 and TGF RII. Cells stimulated with 10 ng/ml TGF-1 (R&D systems) were used in both static and flow conditions. Staining was performed by fixing cells in 4% paraformaldehyde, followed by cell permeabilization in 0.5% Triton-X 100. Non-specific protein binding was blocked with 1% BSA in PBS after which the cells were incubated with primary antibodies (Table 1) . Cells were then mounted in DAPI containing anti-fade reagent and viewed under a fluorescent microscope (Zeiss Axioplan2, Imaging with software proplus 7.0.1).
TGF-1 protein expression was detected in dermal fibroblasts subjected a flow rate of 150 µl/ min for 24 h., followed by immunofluorescence staining as described above.
Quantitative PCR analysis
Total RNA (100ng) was used as a template for cDNA synthesis using the High- 
Enzyme linked immunosorbent assay (ELISA)
Conditioned medium from cells were concentrated 5 times using Amicon Ultra-15
Centrifugal Filter Units. Cellular lysate samples were obtained using RIPA lysis buffer containing protease inhibitors and the protein concentration was determined as above. Activin A and TGF-1 concentration was determined using Activin A Quantikine ELISA Kit and TGF 1 Emax® ImmunoAssay System (Promega Corporation), respectively, according to manufacturer s instructions. Activin A and TGF-1 concentration was estimated using the absorbance values of the standard curve and interpolating the test sample absorbance values using Graphpad Prism 7.
Statistical analyses
Statistical significance of data was tested using one way ANOVA with multiple comparisons test using Graph pad Prism.
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